A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO)

BACKGROUND: Elderly patients are commonly under-represented in cancer clinical trials. The 321GO was undertaken in preparation for a definitive phase three trial assessing different chemotherapy regimens in a frail and/or elderly population with advanced gastroesophageal (GO) cancer. METHODS: Patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, P S, Lord, S R, Collinson, M, Marshall, H, Jones, M, Lowe, C, Howard, H, Swinson, D, Velikova, G, Anthoney, A, Roy, R, Dent, J, Cheeseman, S, Last, K, Seymour, M T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318975/
https://www.ncbi.nlm.nih.gov/pubmed/28095397
http://dx.doi.org/10.1038/bjc.2016.442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318975/
https://www.ncbi.nlm.nih.gov/pubmed/28095397
http://dx.doi.org/10.1038/bjc.2016.442

Ejemplares similares